The global prevalence of nonalcoholic fatty liver disease (NAFLD) is estimated to be 25%
and continues to rise worldwide in the setting of the obesity epidemic. This increase is …

Background & Aims Bariatric surgery has been reported to lead to complete resolution of
nonalcoholic fatty liver disease (NAFLD) following the sustained weight loss induced in …

This update of evidence-based guidelines (GL) aims to translate current evidence and
expert opinion into recommendations for multidisciplinary teams responsible for the optimal …

Non-alcoholic fatty liver disease (NAFLD), specifically its progressive form non-alcoholic
steatohepatitis (NASH), represents the fastest growing indication for liver transplantation in …

High-level evidence of the impact of bariatric surgery on nonalcoholic fatty liver disease
(NAFLD) is lacking. We conducted a systematic review and meta-analysis according to the …

Background Non-alcoholic fatty liver disease (NAFLD) is becoming a leading cause of
global liver disease that is associated with the rising prevalence of obesity worldwide. There …

Nonalcoholic fatty liver disease (NAFLD) is among the most common causes of chronic liver
disease in the western world. It is now recognized that these patients have myriad of …

BACKGROUND & AIMS: Weight loss in overweight or obese individuals results in marked
improvement or resolution of hypertension, diabetes mellitus, and hyperlipidemia. However …

BACKGROUND & AIMS: Severe obesity is implicated in development of nonalcoholic fatty
liver disease (NAFLD). Bariatric surgery induces weight loss and increases survival time of …

The aim of this study was to determine if orlistat, an inhibitor of fat absorption, combined with
caloric restriction in overweight subjects with nonalcoholic steatohepatitis results in weight …